GUTSFractyl Health Inc. Common Stock
0.7800USD+13.70%Mkt Cap: 124.16M $P/E: —3d ago
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to dura…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap124.16M $
Enterprise Value122.65M $
Revenue (TTM)—
Gross Profit0 $
Net Income (TTM)-140.95M $
Revenue/Share—
Last Price0.7800 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees100
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.56
PEG—
EV/EBITDA-1.45
EV/Revenue—
P/S—
P/B-68.51
EPS (TTM)-0.89
EPS (Forward)-0.44
52W Range
0.377019% of range2.445
52W High2.445 USD
52W Low0.3770 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-1490.32%
ROA-116.11%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-90.33M $
CapEx (TTM)557.00K $
FCF Margin—
FCF Yield-38.95%
Net Debt13.60M $
Net Debt/EBITDA-0.16
Balance Sheet
Debt/Equity6.52
Current Ratio3.15
Quick Ratio3.00
Book Value/Sh-0.0100 USD
Cash/Share0.2960 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.033 USD
Upside (mean)+545.3%
Target Range2.000 USD – 8.000 USD
$2.000+545.3% to mean$8.000
# Analysts6
Ownership
Shares Out.159.18M
Float145.87M
Insiders1.35%
Institutions51.51%
Short Interest
Short Ratio1.7d
Short % Float2.11%
Short % Out.1.97%
Shares Short3.12M
Short (prev mo.)2.31M
Technical
SMA 500.7580 (+2.9%)
SMA 2000.9941 (-21.5%)
Beta2.32
S&P 52W Chg18.16%
Avg Vol (30d)1.73M
Avg Vol (10d)1.04M
Technical Indicators
RSI (14)58.3
MACD-0.0170
MACD Signal-0.0244
MACD Hist.+0.0074
BB Upper0.7855 USD
BB Middle0.7046 USD
BB Lower0.6238 USD
BB Width22.96%
ATR (14)0.0571 USD
Vol Ratio (20d)2.74x